| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.09.25 | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 426 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 19, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025,... ► Artikel lesen | |
| 13.09.25 | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 764 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025)... ► Artikel lesen | |
| XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
| 04.09.25 | CSE Bulletin: Suspension - XEBRA Brands Ltd. (XBRA) | 486 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 4 septembre/September 2025) - Effective immediately, XEBRA Brands Ltd. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt... ► Artikel lesen | |
| 04.09.25 | XFRA 9YC0: AUSSETZUNG/SUSPENSION | 405 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXEBRA BRANDS CL.A... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 48,480 | -1,28 % | Bayer-Aktie: Score 1 - Warum das Rekordurteil nichts ändert - Warren Wise Podcast | Ein Risiko weniger ist noch keine Rendite: Der Oberste US-Gerichtshof hat im langen Glyphosat-Streit zugunsten von Bayer entschieden. Die Aktie sprang daraufhin deutlich nach oben. Trotzdem steht Bayer... ► Artikel lesen | |
| AURORA CANNABIS | 3,400 | -0,87 % | Aurora Cannabis: Übernahmekampf erreicht neue Stufe | ||
| CANOPY GROWTH | 0,844 | -1,01 % | Canopy Growth Corporation: Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows | Renewed certification maintains Kincardine's role in Canopy Growth's EU GMP flower supply chain
Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX: WEED) (Nasdaq: CGC)... ► Artikel lesen | |
| TILRAY BRANDS | 3,925 | -0,13 % | Tilray Brands, Inc.: BrewDog triumphiert bei den World Beer Awards 2026 mit herausragender Braukunst | Hazy Jane, Wingman und Mackie's Two Scoops werden mit Goldmedaillen und dem Scotland Country Winner Award ausgezeichnet. Zu den besten Bieren der Welt zählen auch Punk IPA, Lost Lager, Black Heart und... ► Artikel lesen | |
| INNOCAN PHARMA | 1,310 | -1,50 % | InnoCan Pharma im Krisenmodus: Trotz 29,7% Umsatzplus neues Allzeittief | ||
| CRONOS GROUP | 2,892 | -0,55 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| SYNBIOTIC | 0,698 | +1,90 % | Portfolio unwound; rating placed Under Review: Wave of portfolio insolvencies narrows SYNBIOTIC to WEECO ... | SYNBIOTIC's investment case has changed fundamentally after a wave of insolvencies and liquidations across the portfolio. What began with the Bushdoctor (Austria) insolvency in December 2025 has widened... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 64,46 | +0,75 % | Nektar Therapeutics Announces Second Quarter 2026 Financial Results | SAN FRANCISCO, Aug. 13, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 4,380 | -0,11 % | Oramed Pharmaceuticals Inc.: Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet | Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million)
Scilex (NASDAQ: SCLX) Loan Substantially Repaid
Total Cash and Assets Build... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 13,100 | 0,00 % | When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges | ||
| OPKO HEALTH | 1,270 | -1,55 % | OPKO Health, Inc.: OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests | MIAMI, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the expansion of its financing relationship with HealthCare Royalty, a business of KKR (HCRx), through... ► Artikel lesen | |
| JAGUAR HEALTH | 0,870 | +0,58 % | Jaguar Health, Inc.: Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs | Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool consistency and GI... ► Artikel lesen | |
| XORTX THERAPEUTICS | 1,920 | +2,24 % | XORTX Therapeutics Inc. GAAP EPS of -$1.05 | ||
| CURALEAF | 8,030 | -0,09 % | Aurora Cannabis: Curaleaf kontert - was jetzt droht | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 23.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.04.2026ISIN NameAU000000BMG3 BMG... ► Artikel lesen |